Augmenting Markov Cohort Analysis to Compute (Co)Variances: Implications for Strength of Cost-Effectiveness
Published Online:13 Sep 2022https://doi.org/10.1287/ijoc.2022.1234
References
- (2009) The half-cycle correction: Banish rather than explain it. Medical Decision Making 29:500–502.Crossref, Google Scholar
- (1983) The Markov process in medical prognosis. Medical Decision Making 3(4):419–458.Crossref, Google Scholar
- (2006) Decision Modeling for Health-Economic Evaluation (Oxford University Press, Oxford, UK).Crossref, Google Scholar
- (1997) Modelling the cost-effectiveness of lamivudine/zidovudine combination therapy in HIV infection. PharmacoEconomics 12:1–13.Crossref, Google Scholar
- (2005) Methods for the Economic Evaluation of Healthcare Programmes (Oxford University Press, Oxford, UK).Crossref, Google Scholar
- (1989) Variance-penalized Markov decision processes. Math. Oper. Res. 14(1):147–161.Link, Google Scholar
- (2021) Augmenting Cohort Analysis to Compute (Co-)Variances: Implications for Strength of Cost-Effectiveness (Department of Industrial Engineering and Management Sciences, Northwestern University, Evanston, IL).Google Scholar
- (2018) A theoretical foundation for state-transition cohort models in health decision analysis. PLoS One 13(12):e0205543. https://doi.org/10.1371/journal.pone.0205543.Crossref, Google Scholar
- (1960) Finite Markov Chains (Springer-Verlag, New York).Google Scholar
- (2017) Using cost-effectiveness analysis in health and medicine: Experiernces since the original panel. Neumann PJ, Sanders PG, Russell LB, Siegel JE, Ganiats TG, eds. Cost-Effectiveness in Health and Medicine (Oxford University Press, New York), 1–37.Google Scholar
- (1994) Probability Models and Applications (Macmillan, New York).Google Scholar
- (1982) The variance of discounted Markov decision processes. J. Appl. Probabilities 19(4):794–802.Crossref, Google Scholar
- (1993) Markov models in medical decision making. Medical Decision Making 13(4):322–338.Crossref, Google Scholar

